Abnormal polyglutamine (polyQ) tracts are the only common feature in nine proteins that each cause a dominant neurodegenerative disorder. In Huntington's disease, tracts longer than 36 glutamines in the protein huntingtin (htt) cause degeneration. In situ, monoclonal antibody 3B5H10 binds to different htt fragments in neurons in proportion to their toxicity. Here, we determined the structure of 3B5H10 Fab to 1.9 Å resolution by X-ray crystallography. Modeling demonstrates that the paratope forms a groove suitable for binding two β-rich polyQ strands. Using small-angle X-ray scattering, we confirmed that the polyQ epitope recognized by 3B5H10 is a compact two-stranded hairpin within monomeric htt and is abundant in htt fragments unbound...
Soluble huntingtin exon 1 (Httex1) with expanded polyglutamine (polyQ) engenders neurotoxicity in Hu...
Aggregation of huntingtin (htt) in neuronal inclusions is associated with the development of Hunting...
Conformational changes in disease-associated or mutant proteins represent a key pathological aspect ...
Abnormal polyglutamine (polyQ) tracts are the only common feature in nine proteins that each cause a...
Abnormal polyglutamine (polyQ) tracts are the only common feature in nine proteins that each cause a...
Huntington's disease is caused by expansion of a polyglutamine (polyQ) repeat in the huntingtin prot...
International audienceEight neurodegenerative diseases have been shown to be caused by the expansion...
Huntington disease (HD) is a neurodegenerative disorder caused by an expansion of a polyglutamine (p...
Huntington’s disease, like other neurodegenerative diseases, continues to lack an effective cure. Cu...
The abnormal amplification of a CAG repeat in the gene coding for huntingtin (HTT) leads to Huntingt...
Huntington's disease is caused by expansion of a polyglutamine (polyQ) repeat in the huntingtin prot...
Huntington's disease is a neurodegenerative disease caused by a polyglutamine (polyQ) expansion in H...
Huntington's disease (HD) is caused by an expanded glutamine tract, which confers a novel aggregatio...
Huntington's disease (HD) is caused by an expanded glutamine tract, which confers a novel aggregatio...
SummaryHuntington's disease is a genetic neurodegenerative disorder resulting from polyglutamine (po...
Soluble huntingtin exon 1 (Httex1) with expanded polyglutamine (polyQ) engenders neurotoxicity in Hu...
Aggregation of huntingtin (htt) in neuronal inclusions is associated with the development of Hunting...
Conformational changes in disease-associated or mutant proteins represent a key pathological aspect ...
Abnormal polyglutamine (polyQ) tracts are the only common feature in nine proteins that each cause a...
Abnormal polyglutamine (polyQ) tracts are the only common feature in nine proteins that each cause a...
Huntington's disease is caused by expansion of a polyglutamine (polyQ) repeat in the huntingtin prot...
International audienceEight neurodegenerative diseases have been shown to be caused by the expansion...
Huntington disease (HD) is a neurodegenerative disorder caused by an expansion of a polyglutamine (p...
Huntington’s disease, like other neurodegenerative diseases, continues to lack an effective cure. Cu...
The abnormal amplification of a CAG repeat in the gene coding for huntingtin (HTT) leads to Huntingt...
Huntington's disease is caused by expansion of a polyglutamine (polyQ) repeat in the huntingtin prot...
Huntington's disease is a neurodegenerative disease caused by a polyglutamine (polyQ) expansion in H...
Huntington's disease (HD) is caused by an expanded glutamine tract, which confers a novel aggregatio...
Huntington's disease (HD) is caused by an expanded glutamine tract, which confers a novel aggregatio...
SummaryHuntington's disease is a genetic neurodegenerative disorder resulting from polyglutamine (po...
Soluble huntingtin exon 1 (Httex1) with expanded polyglutamine (polyQ) engenders neurotoxicity in Hu...
Aggregation of huntingtin (htt) in neuronal inclusions is associated with the development of Hunting...
Conformational changes in disease-associated or mutant proteins represent a key pathological aspect ...